Jiangsu

Koppers Chief Financial Officer Michael Zugay Earns Career Achievement Award

Retrieved on: 
Monday, November 8, 2021
Treasury, American, Retirement, Pleasure, Growth, New, KJCC, COVID-19, Multimedia, American City Business Journals, Agriculture, Program, Aluminium, Sale, Acquisition, Carbon, Rubber industry in Malaysia, Jiangsu, NYSE, Communication, Steel, KOP, CFO, Pharmaceutical industry, Management

PITTSBURGH, Nov. 8, 2021 /PRNewswire/ --Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, todayannounced that Chief Financial Officer Michael Zugay has been recognized by the Pittsburgh Business Times with the CFO of the Year Career Achievement Award.

Key Points: 
  • PITTSBURGH, Nov. 8, 2021 /PRNewswire/ --Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals, and carbon compounds, todayannounced that Chief Financial Officer Michael Zugay has been recognized by the Pittsburgh Business Times with the CFO of the Year Career Achievement Award.
  • The annual award celebrates financial leaders who have made exemplary contributions to their profession over the course of their careers.Zugay has announced his retirement from Koppers, effective December 31, 2021.
  • "This is an unexpected honor, and my appreciation goes to the Pittsburgh Business Times as well asthe Koppers team for the nomination," said Zugay.
  • Inquiries from the investment community should be directed to Mr. Michael Zugay at 412-227-2231 or Ms.Quynh McGuireat 412-227-2049.

Skillful Craftsman Provides Update on Chinese Central Authorities’ Issued Opinions on Promoting the High-quality Development of Modern Vocational Education

Retrieved on: 
Thursday, October 14, 2021
State Council, Goal, Social capital, Industry, Private Securities Litigation Reform Act, Vocational education, Time, Intention, Employment, General officer, Renewable energy, Central committee, General Office of the State Council, Education, Australian Financial Review, Artificial intelligence, GLOBE, Forward-looking statement, University, Company, Annual report, Entrepreneurship, Opinion, NASDAQ, Communist party, Research, Industrial design, Audit

The Opinions contains a set of guidelines on promoting the high-quality development of modern vocational education.

Key Points: 
  • The Opinions contains a set of guidelines on promoting the high-quality development of modern vocational education.
  • The Opinions encourages public-listed companies and industry leading enterprises to participate in investment in vocational education and support vocational schools to cooperate with social capital to build the infrastructure and practical training facilities for vocational education.
  • We are currently working with several universities and vocational colleges to build online education infrastructure and provide more curriculums and we will strive to promote the high-quality development of Chinas modern vocational education.
  • Skillful Craftsman is an education technology company that provides interactive online vocational training and virtual simulation experimental training courses.

Adagene to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

Retrieved on: 
Thursday, September 2, 2021
GLOBE, Artificial intelligence, Science, Computational biology, DPL, Antibody, Investor, Morgan, SAN, Conference, Q&A, Morgan Stanley, Technology, Fine chemical

SAN FRANCISCO, Calif. and SUZHOU, China, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (Adagene) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagenes Co-founder, Chief Executive Officer and Chairman,Peter Luo, Ph.D., will participate in the Morgan Stanley 19th Annual Global Healthcare Conference to be held virtually September 9-15, 2021.

Key Points: 
  • SAN FRANCISCO, Calif. and SUZHOU, China, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (Adagene) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagenes Co-founder, Chief Executive Officer and Chairman,Peter Luo, Ph.D., will participate in the Morgan Stanley 19th Annual Global Healthcare Conference to be held virtually September 9-15, 2021.
  • Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
  • Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs.
  • Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates

Retrieved on: 
Thursday, August 26, 2021

Preliminary data from this trial demonstrate target engagement as shown by a dose-dependent pharmacodynamic biomarker, consistent with the monotherapy trials.

Key Points: 
  • Preliminary data from this trial demonstrate target engagement as shown by a dose-dependent pharmacodynamic biomarker, consistent with the monotherapy trials.
  • The net loss attributable to Adagene Inc.s shareholders was US$37.2 million for the six months ended June 30, 2021, compared to US$18.2 million for the six months ended June 30, 2020.
  • Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
  • Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)

Retrieved on: 
Thursday, August 19, 2021
Immunoglobulin G, Liver, FC, Cancer, U.S. Securities and Exchange Commission, Syngenic, Technology, Trial of the century, GLOBE, Immune system, Survival, Artificial intelligence, Science, Computational biology, DPL, Mab, Merck & Co., Antibody, Intellectual property, Clinical trial, CD137, Safety, Partnership, Patient, SAN, COVID-19, Lymphatic system, Pharmaceutical industry

This clinical study builds on the promising monotherapy and combination therapy data from a Phase I trial of ADG106.

Key Points: 
  • This clinical study builds on the promising monotherapy and combination therapy data from a Phase I trial of ADG106.
  • We are excited to continue our partnership with Merck in a third clinical collaboration that now combines our anti-CD137 agonist, ADG106, with KEYTRUDA, said Peter Luo, Ph.D., Co-founder, Chief Executive Officer and Chairman of Adagene.
  • We look forward to working closely with Merck and combining ADG106 with KEYTRUDA, said Steven Fischkoff, M.D., interim Chief Medical Officer of Adagene.
  • KEYTRUDA is a registered trademark ofMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,Kenilworth, NJ, USA.

Skillful Craftsman Announces Director Change

Retrieved on: 
Monday, August 16, 2021
Time, Goal, Forward-looking statement, Company, Private Securities Litigation Reform Act, Board, Sustainability Accounting Standards Board, Intention, Audit

Mr. Xiaofeng Gao, Chairman and Co-Chief Executive Officer of Skillful Craftsman, commented, We are excited to welcome Mr. Shaowei Zhang to join us.

Key Points: 
  • Mr. Xiaofeng Gao, Chairman and Co-Chief Executive Officer of Skillful Craftsman, commented, We are excited to welcome Mr. Shaowei Zhang to join us.
  • Mr. Shaowei Zhang, Director of Skillful Craftsman, stated, I am excited to join Skillful Craftsman as a key supporter for Chinas education reform and development for labor employment with relentless focus on providing interactive online vocational training and virtual simulation experimental training courses.
  • I look forward to partnering with the Board as the company continues to advance education technology and explore vocational education market."
  • Skillful Craftsman is an education technology company that provides interactive online vocational training and virtual simulation experimental training courses.

Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board

Retrieved on: 
Thursday, August 12, 2021

- Dr. Fischkoff serves as the interim Chief Medical Officer of Adagene and is a member of the companys SAB.

Key Points: 
  • - Dr. Fischkoff serves as the interim Chief Medical Officer of Adagene and is a member of the companys SAB.
  • He is a board-certified medical oncologist who has been active in the pharmaceutical industry for approximately 30 years.
  • He is Chief Medical Officer at Cytovia Therapeutics and is a Non-Executive Director at Precision Biosciences.
  • Dr. Spiegel has been a consultant to the biotech industry and has served on the scientific advisory board and board of directors of multiple biotech companies.

Skillful Craftsman Announces Strategic Partnership with Major Flexible Staffing Platform in Jiangsu Province

Retrieved on: 
Tuesday, August 10, 2021
Industry, Intention, Research report, CEO, School, Company, Annual report, Mercer (consulting firm), Private Securities Litigation Reform Act, Partnership, Time, Forward-looking statement, Australian Financial Review, WTH, Vocational education, Policy, Goal, Awareness, NASDAQ, GLOBE, Tutoring, Medicine, Audit

WUXI, China, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Ltd. (the Company or Skillful Craftsman) (NASDAQ: EDTK), an education technology company providing interactive online learning services, today announced a strategic partnership with Wuxi Talent Home Information Technology Co., Ltd. (WTH), one of the largest flexible staffing platforms in Jiangsu Province.

Key Points: 
  • WUXI, China, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Ltd. (the Company or Skillful Craftsman) (NASDAQ: EDTK), an education technology company providing interactive online learning services, today announced a strategic partnership with Wuxi Talent Home Information Technology Co., Ltd. (WTH), one of the largest flexible staffing platforms in Jiangsu Province.
  • The partnership will combine Skillful Craftsmans expertise in vocational education with WTHs leadership in the regional flexible staffing market to better serve talents and employers.
  • Despite the huge market potential, many flexible staffing platforms in China do not have technical advantage and brand awareness.
  • Therefore, the combination of a flexible staffing platform and a skill training platform will be a reliable cornerstone for building brand awareness and establishing technical barriers.

Skillful Craftsman Announces Officer Changes

Retrieved on: 
Friday, August 6, 2021
Growth, Knowledge, Industry, Company, Strategic planning, Private Securities Litigation Reform Act, Wall Street, MBA, Beijing Jiaotong University, Master of Business Administration, Intention, Jiaotong University, Forward-looking statement, NASDAQ, Citigroup, Technology, Chief, Business administration, Banco Santander, Beijing University of Posts and Telecommunications, Skill, 2015 IIHF Women's Challenge Cup of Asia Division I, China Europe International Business School, South China University of Technology, Concordia University, Time, Master of Engineering Management, GLOBE, Investment, Education, Goal, Initial public offering, BJTU, Management, Audit

WUXI, China, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Ltd. (the Company or Skillful Craftsman) (NASDAQ: EDTK), an education technology company providing interactive online learning services, today announced a few officer changes, which have taken effect on August 6, 2021.

Key Points: 
  • WUXI, China, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Ltd. (the Company or Skillful Craftsman) (NASDAQ: EDTK), an education technology company providing interactive online learning services, today announced a few officer changes, which have taken effect on August 6, 2021.
  • Mr. Xiaofeng Gao, Chairman and Co-Chief Executive Officer of Skillful Craftsman, commented, We are excited to strengthen our executive management team to grow our business and accelerate our next phase of growth.
  • Mr. Dawei Chen, Chief Financial Officer of Skillful Craftsman, stated, I am honored to serve as the Chief Financial Officer and continue executing on the strategic vision.
  • Mr. Bill Tang, Chief Strategy Officer of Skillful Craftsman, said, I am delighted to join the management of Skillful Craftsman.

Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)

Retrieved on: 
Thursday, July 22, 2021
Cancer treatments, Clinical medicine, Drugs, Cancer immunotherapy, Bayer, Kenilworth, New Jersey, Merck & Co., Schering-Plough, Merck, Pembrolizumab

This collaboration with Merck and the advancement of our global clinical studies represent an important milestone in our comprehensive CTLA-4 clinical development program, said Peter Luo, Ph.D., Co-founder, Chief Executive Officer and Chairman of Adagene.

Key Points: 
  • This collaboration with Merck and the advancement of our global clinical studies represent an important milestone in our comprehensive CTLA-4 clinical development program, said Peter Luo, Ph.D., Co-founder, Chief Executive Officer and Chairman of Adagene.
  • We are fortunate to have the opportunity to explore this combination with Merck and tackle two of the most potent immunotherapy targets.
  • KEYTRUDA is a registered trademark ofMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,Kenilworth, NJ, USA.
  • In the ADG116-1003 trial, ADG116 has been well tolerated in 17 patients, with no dose-limiting toxicities or unexpected safety signals.